Bill Anderson to become CEO of Bayer AG

The Supervisory Board of Bayer AG (BAYRY) has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werner Baumann, current CEO of Bayer, will work closely with him on a smooth transition before retiring from Bayer after 35 years of service at the end of May 2023. Bill Anderson, a chemical engineer by education, has served in various leadership positions in the life science industry over the past 25 years. Most recently, he served as CEO of Roche’s (RHHBY) Pharmaceuticals Division, where he led a comprehensive transformation program which resulted in many new product launches, revenue growth, and greater productivity across the organization. Reference Link